Patients in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation trial ( N = @,@ ) were stratified by AAD use at baseline : amiodarone , other AAD , or no AAD .